Reliability and Minimal Detectable Change of Physical Performance Measures in Individuals With Pre-manifest and Manifest Huntington Disease.

Background. Clinical intervention trials in people with Huntington disease (HD) have been limited by a lack of reliable and appropriate outcome measures. Objective. The purpose of this study was to determine the reliability and minimal detectable change (MDC) of various outcome measures that are pot...

Descripción completa

Detalles Bibliográficos
Publicado en:Physical Therapy Vol. 93; no. 7; pp. 942 - 957
Autores principales: Quinn, Lori, Khalil, Hanan, Dawes, Helen, Fritz, Nora E., Kegelmeyer, Deb, Kloos, Anne D., Gillard, Jonathan W., Busse, Monica
Formato: research tables/charts Journal Article
Publicado: Oxford University Press / USA Jul2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104215188&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104215188
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00319023
        PTH
      jtl: Physical Therapy
      issn: 00319023
      maglogo: N
    pubinfo:
      dt: Jul2013
      vid: 93
      iid: 7
      pid: 10398
      pub: Oxford University Press / USA
    artinfo:
      ui:
        104215188
        89857556
        10.2522/ptj.20130032
        NLM23520147
        104215188
      ppf: 942
      ppct: 15
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Reliability and Minimal Detectable Change of Physical Performance Measures in Individuals With Pre-manifest and Manifest Huntington Disease.
      aug:
        au:
          Quinn, Lori
          Khalil, Hanan
          Dawes, Helen
          Fritz, Nora E.
          Kegelmeyer, Deb
          Kloos, Anne D.
          Gillard, Jonathan W.
          Busse, Monica
        affil: School of Healthcare Studies, Cardiff University, Ty Dewi Sant, Health Park, Cardiff, CF14 4XN United Kingdom
      sug:
        subj:
          Huntington's Disease Physiopathology
          Outcome Assessment Methods
          Functional Status
          Functional Assessment Methods
          Clinical Assessment Tools Evaluation
          Exercise Test
          Barthel Index
          Clinical Assessment Tools
          Scales
          Questionnaires
          Multicenter Studies
          Prospective Studies
          Test-Retest Reliability
          Intraclass Correlation Coefficient
          Cross Sectional Studies
          Data Analysis Software
          Confidence Intervals
          Comparative Studies
          Adult
          Middle Age
          Female
          Male
          Human
          Funding Source
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Background. Clinical intervention trials in people with Huntington disease (HD) have been limited by a lack of reliable and appropriate outcome measures. Objective. The purpose of this study was to determine the reliability and minimal detectable change (MDC) of various outcome measures that are potentially suitable for evaluating physical functioning in individuals with HD. Design. This was a multicenter, prospective, observational study. Methods. Participants with pre-manifest and manifest HD (early, middle, and late stages) were recruited from 8 international sites to complete a battery of physical performance and functional measures at 2 assessments, separated by 1 week. Test-retest reliability (using intraclass correlation coefficients) and MDC values were calculated for all measures. Results. Seventy-five individuals with HD (mean age52.12 years, SD11.82) participated in the study. Test-retest reliability was very high (.90) for participants with manifest HD for the Six-Minute Walk Test (6MWT), 10-Meter Walk Test, Timed “Up & Go” Test (TUG), Berg Balance Scale (BBS), Physical Performance Test (PPT), Barthel Index, Rivermead Mobility Index, and Tinetti Mobility Test (TMT). Many MDC values suggested a relatively high degree of inherent variability, particularly in the middle stage of HD. Minimum detectable change values for participants with manifest HD that were relatively low across disease stages were found for the BBS (5), PPT (5), and TUG (2.98). For individuals with pre-manifest HD (n11), the 6MWT and Four Square Step Test had high reliability and low MDC values. Limitations. The sample size for the pre-manifest HD group was small. Conclusions. The BBS, PPT, and TUG appear most appropriate for clinical trials aimed at improving physical functioning in people with manifest HD. Further research in people with pre-manifest HD is necessary.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N